Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency

about

Solid-in-oil nanodispersions for transdermal drug delivery systems.

P2860

Q38830870-5B615DE3-884B-40A8-942D-591C4E95364E

P2860

Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency

Item

http://www.wikidata.org/entity/Q42733178

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Use of lipolanthionine peptide ...... ransdermal delivery efficiency

@en

Use of lipolanthionine peptide ...... ransdermal delivery efficiency

@nl

type

Item

label

Use of lipolanthionine peptide ...... ransdermal delivery efficiency

@en

Use of lipolanthionine peptide ...... ransdermal delivery efficiency

@nl

prefLabel

Use of lipolanthionine peptide ...... ransdermal delivery efficiency

@en

Use of lipolanthionine peptide ...... ransdermal delivery efficiency

@nl

P1476

Use of lipolanthionine peptide ...... ransdermal delivery efficiency

@en

P2093

Bin Chen

http://www.w3.org/2001/XMLSchema#string

Da-Lie Liu

http://www.w3.org/2001/XMLSchema#string

Jia Wang

http://www.w3.org/2001/XMLSchema#string

Jia-Bao Shou

http://www.w3.org/2001/XMLSchema#string

Ju-Hua Wu

http://www.w3.org/2001/XMLSchema#string

Qing-Long Mao

http://www.w3.org/2001/XMLSchema#string

Wen-Yan Pan

http://www.w3.org/2001/XMLSchema#string

Xiao-Hui Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis

Toll-like receptors in the induction of the innate immune response

Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.

GM-CSF priming drives bone marrow-derived macrophages to a pro-inflammatory pattern and downmodulates PGE2 in response to TLR2 ligands

Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors

Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-κB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts

Penetration enhancement of transdermal delivery--current permutations and limitations.

A review on bioadhesive buccal drug delivery systems: current status of formulation and evaluation methods

Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.

Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery.

P304

593-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2014.2251

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262611735

http://www.w3.org/2001/XMLSchema#string

P698

24858729

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4094769

http://www.w3.org/2001/XMLSchema#string

Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency

about

P2860

P2860

Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932